Serving To Educate Primary Care Clinicians On Respiratory Issues
Home
Subscribe
Feedback
Contact Us
Evidence Based Medicine
Medical Education
Metabolic Diseases
About Us
Publications
Educational Activities
Education
Resources
Needs Survey
Commentaries
News
Asthma Webinar Pre
Which of the following is true about use of anti-inflammatory therapies (corticosteroids) in patients with asthma?
Systemic corticosteroids are an effective, low-risk method for treating most asthma exacerbations.
Anti-inflammatory airway effects of inhaled corticosteroids do not occur until 2-3 days of consecutive use.
For patients with mild asthma, SABA-only rescue therapy is preferred to ICS-containing rescue regimens due to improved outcomes and lower corticosteroid exposure.
Adding ICS to a fast-acting bronchodilator for rescue or rescue and maintenance therapy results in fewer exacerbations compared to SABA-only rescue therapy.
Which of the following is true about use of SABA in patients with asthma?
SABA-only rescue therapy is recommended for patients with mild asthma (step 1) in the GINA 2022 Report.
Increasing SABA use is associated with a higher risk of exacerbations.
SABA + ICS rescue therapy is equally as effective for preventing and treating exacerbations as SABA-only rescue therapy.
There are currently several FDA-approved SABA + ICS combination inhalers available in the United States.
How confident do you feel in your answer to the previous question?
Select...
Very confident
Confident
Somewhat confident
Not confident